Accurate cleavage and polyadenylation of exogenous RNA substrate.
Purified precursor RNA containing the L3 polyadenylation site of late adenovirus 2 mRNA is accurately cleaved and polyadenylated when incubated with nuclear extract from HeLa cells. The reaction is very efficient; 75% of the precursor is correctly processed. Cleavage is rapidly followed by polymerization of an initial poly(A) tract of approximately 130 nucleotides. Additional adenosine residues are added during further incubation. In the presence of the ATP analog alpha-beta-methylene-adenosine 5' triphosphate, the precursor RNA is cleaved but not polyadenylated, suggesting that processing is not coupled to the synthesis of the initial poly(A) tract. In the absence of free Mg2+, a small RNA of approximately 46 nucleotides is stabilized against degradation. Fingerprint analysis suggests this RNA is produced by endonucleolytic cleavage at the L3 site. Like the in vitro splicing reaction, the in vitro polyadenylation reaction is inhibited by adding antiserum against the small nuclear ribonucleoprotein particle containing U1 RNA.
C L
CL
Moore
P A
PA
Sharp
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000260:Adenoviruses, Human; D001483:Base Sequence; D006367:HeLa Cells; D006801:Humans; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D009694:Nucleic Acid Precursors / Q000378:metabolism*; D011061:Poly A / Q000378:metabolism*; D012313:RNA / Q000378:metabolism*; D012315:RNA Caps / Q000502:physiology; D012322:RNA Precursors; D012323:RNA Processing, Post-Transcriptional; D012333:RNA, Messenger; D012367:RNA, Viral / Q000378:metabolism*; D012261:Ribonucleoproteins / Q000502:physiology; D017411:Ribonucleoproteins, Small Nuclear
D009694:Nucleic Acid Precursors; D012315:RNA Caps; D012322:RNA Precursors; D012333:RNA, Messenger; D012367:RNA, Viral; D012261:Ribonucleoproteins; D017411:Ribonucleoproteins, Small Nuclear; D011061:Poly A; D012313:RNA; D000255:Adenosine Triphosphate; D008274:Magnesium